Vermillion Posts $431K in Q1 Revenues

The company said that it has launched the OVA1 test in India and announced a partnership with Qiagen to offer a medical education program in ovarian and cervical cancers.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories